Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
VA San Diego Healthcare System
mi
from
San Diego, CA
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Associates Research LLC
mi
from
Covington, LA
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Associates Research LLC
mi
from
Covington, LA
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petoskey, MI
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Cardiac and Vascular Research Center of Northern Michigan
mi
from
Petoskey, MI
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Missouri Health System
mi
from
Columbia, MO
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Missouri Health System
mi
from
Columbia, MO
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Buffalo Heart Group LLP
mi
from
Buffalo, NY
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Buffalo Heart Group LLP
mi
from
Buffalo, NY
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Veterans Affairs WNY Healthcare System
mi
from
Buffalo, NY
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs WNY Healthcare System
mi
from
Buffalo, NY
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Novant Health Heart and Vascular Institute
mi
from
Charlotte, NC
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Novant Health Heart and Vascular Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
Concord Repatriation General Hospital
mi
from
Concord,
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
Concord Repatriation General Hospital
mi
from
Concord,
Click here to add this to my saved trials
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated:  12/31/1969
VA Eastern Colorado Health Care System
mi
from
Denver, CO
CER-001 Atherosclerosis Regression ACS Trial
CER-001 Atherosclerosis Regression ACS Trial; A Phase II Multi-Center, Double-Blind, Placebo-Controlled, Dose-Focusing Trial Of Cer-001 In Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 12/31/1969
VA Eastern Colorado Health Care System
mi
from
Denver, CO
Click here to add this to my saved trials
Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle Anatomy
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle Anatomy
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
Status: Enrolling
Updated:  12/31/1969
Aultman Health Foundation
mi
from
Canton, OH
Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
Status: Enrolling
Updated: 12/31/1969
Aultman Health Foundation
mi
from
Canton, OH
Click here to add this to my saved trials
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Podocan and Wnt Pathway in Left Ventricular Remodeling of Aortic Stenosis
Clinical Predictive Value of Podocan and Wnt Pathway Regulatory Molecules on Maladaptive Left Ventricular Response in Aortic Stenosis
Status: Enrolling
Updated:  12/31/1969
Bassett Healthcare Network
mi
from
Cooperstown, NY
Podocan and Wnt Pathway in Left Ventricular Remodeling of Aortic Stenosis
Clinical Predictive Value of Podocan and Wnt Pathway Regulatory Molecules on Maladaptive Left Ventricular Response in Aortic Stenosis
Status: Enrolling
Updated: 12/31/1969
Bassett Healthcare Network
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Cilostazol After Lower Extremity Arterial Revascularization Trial
Cilostazol After Lower Extremity Arterial Revascularization Trial (CLEAR)
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Cilostazol After Lower Extremity Arterial Revascularization Trial
Cilostazol After Lower Extremity Arterial Revascularization Trial (CLEAR)
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO Support
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Physical Activity Interventions for Leg Ulcer Patients
Physical Activity Interventions for Leg Ulcer Patients
Status: Enrolling
Updated:  12/31/1969
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Physical Activity Interventions for Leg Ulcer Patients
Physical Activity Interventions for Leg Ulcer Patients
Status: Enrolling
Updated: 12/31/1969
Spartanburg Regional Medical Center
mi
from
Spartanburg, SC
Click here to add this to my saved trials
AiDing Diuresis wIth Tolvaptan (ADD-IT)
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital Midtown
mi
from
Atlanta, GA
AiDing Diuresis wIth Tolvaptan (ADD-IT)
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
AiDing Diuresis wIth Tolvaptan (ADD-IT)
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
AiDing Diuresis wIth Tolvaptan (ADD-IT)
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
Status: Enrolling
Updated:  12/31/1969
LAC Harbor-UCLA Medical Center
mi
from
Torrance, CA
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions
Status: Enrolling
Updated: 12/31/1969
LAC Harbor-UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Utilization of TEG to Monitor Rivaroxaban Activity
Utilization of Thromboelastography to Monitor Rivaroxaban Activity in Trauma and Emergency Surgery Patients
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center, PUH, 200 Lothrop Street
mi
from
Pittsburgh, PA
Utilization of TEG to Monitor Rivaroxaban Activity
Utilization of Thromboelastography to Monitor Rivaroxaban Activity in Trauma and Emergency Surgery Patients
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center, PUH, 200 Lothrop Street
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Aiyan Diabetes Center
mi
from
Augusta, GA
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Aiyan Diabetes Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Salem VA Medical Center
mi
from
Salem, VA
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Salem VA Medical Center
mi
from
Salem, VA
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Advocate Health and Hospitals
mi
from
Oakbrook Terrace, IL
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Advocate Health and Hospitals
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Maryland
mi
from
Baltimore, MD
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Truman Medical Center
mi
from
Kansas City, MO
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Truman Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
New York University
mi
from
New York, NY
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
University of Southern Califiornia
mi
from
Los Angeles, CA
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
University of Southern Califiornia
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
First Coast Cardiovascular Institute
mi
from
Jacksonville, FL
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
First Coast Cardiovascular Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Evanston, IL
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Freeman Health System
mi
from
Joplin, MO
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Freeman Health System
mi
from
Joplin, MO
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
St. Francis Hospital
mi
from
Roslyn, NY
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
St. Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Heart Group of the Eastern Shore
mi
from
Fairhope, AL
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Heart Group of the Eastern Shore
mi
from
Fairhope, AL
Click here to add this to my saved trials
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
Charlotte Heart Group Research Center
mi
from
Port Charlotte, FL
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
Charlotte Heart Group Research Center
mi
from
Port Charlotte, FL
Click here to add this to my saved trials